{'fraction_non_alphanumeric': 0.058782849239280774, 'fraction_numerical': 0.048409405255878286, 'mean_word_length': 4.930327868852459, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Flavonoids intake and risk of prostate cancer: a meta‐analysis of observational studies

The aim of the study was to assess the association between total flavonoids/flavonoid subclasses intake and prostate cancer risk. Several databases were searched to select eligible studies with predefined criteria. Risk ratios (RRs) with 95% confidence intervals (CIs) were used as the effect size. Publication bias and sensitivity analysis were performed. A total of five studies including four prospective cohort studies and one case–control study were included in the meta‐analysis. The pooled result demonstrated a significantly increased risk of prostate cancer with higher intake of total flavonoids (RR = 1.12, 95% CI: 1.02–1.23, P = 0.013). However, sensitivity analysis indicated that there lacked a significant association after removing the study of Wang et al. (RR = 1.17, 95% CI: 0.94–1.46). Subgroup analysis stratified by flavonoids subclasses found that higher intake of anthocyanidins and flavan‐3‐ols were significantly associated with increased prostate cancer risk (RR = 1.12, 95% CI: 1.03–1.21, P = 0.011; RR = 1.21, 95% CI: 1.10–1.32, P < 0.001). Sensitivity analysis also indicated that after removing Wang's study, no significant association between anthocyanidins intake and prostate cancer risk was detected (RR = 1.22, 95% CI: 0.97–1.54). In conclusion, higher intake of flavonoids may not be associated with prostate cancer risk.